DER Reference Model Version 1.0.0
ecqm.dataelement

Antithrombotic Therapy Administered

Description:
Clinical Focus: This set of values contains anticoagulant and antiplatelet drugs used to reduce stroke mortality and morbidity.
Data Element Scope: The intent of this data element is to identify patients who receive antithombotic therapy following stroke. Using the Quality Data Model, this particular element would map to the Medication category.
Inclusion Criteria: Include single and multi-ingredient drugs. Oral, rectal, and injectable dose forms should be included. Antithrombotic medications include anticoagulants and antiplatelet drugs.
Exclusion Criteria: Exclude enoxaparin and heparin codes generally given for VTE prophylaxis.
Subject constrained to the Antithrombotic Therapy
QDM Datatype: MedicationAdministered

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

Used By:
Included in Unions: